William Blair & Company
CELL

William Blair & Company’s PhenomeX Inc. Common Stock CELL Stock Holding History

William Blair & Company’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,850
Closed -$6.3K – 1863
2023
Q2 		$6.3K Sell
12,850
-150
-1% -$123 ﹤0.01% 1754
2023
Q1 		$15.1K Sell
13,000
-55
-0.4% -$101 ﹤0.01% 1702
2022
Q4 		$35K Sell
13,055
-400
-3% -$1.05K ﹤0.01% 1618
2022
Q3 		$38K Hold
13,455
– – ﹤0.01% 1632
2022
Q2 		$67K Sell
13,455
-1,788
-12% -$9.37K ﹤0.01% 1591
2022
Q1 		$108K Sell
15,243
-49,499
-76% -$409K ﹤0.01% 1627
2021
Q4 		$1.18M Sell
64,742
-22,357
-26% -$483K ﹤0.01% 902
2021
Q3 		$1.7M Sell
87,099
-43,555
-33% -$1.66M 0.01% 750
2021
Q2 		$5.86M Buy
130,654
+81,593
+166% +$3.78M 0.02% 428
2021
Q1 		$2.46M Buy
49,061
+46,761
+2,033% +$3.19M 0.01% 621
2020
Q4 		$206K Buy
+2,300
New +$193K ﹤0.01% 1421

Other funds holding CELL

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
TAM
Terrapin Asset Management Miami, Florida $87.8M AUM 16.84% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
CM
Crystalline Management Montreal, Quebec, Canada $112M AUM 21.13% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair & Company's CELL Position: Q3 2023 in Review

William Blair & Company sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 12,850 shares — an estimated $6.3K sold.

William Blair & Company first reported a position in CELL in Q4 2020 and held it in 11 quarters. The position peaked at $5.86M in Q2 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • William Blair & Company reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • William Blair & Company sold 12,850 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $6.3K.
  • William Blair & Company first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 11 quarters.
  • William Blair & Company's PhenomeX Inc. Common Stock position peaked at $5.86M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on William Blair & Company's 13F filing for Q3 2023, filed 9 Nov 2023.